TG THERAPEUTICS INC (TGTX) Stock Income Statement
NASDAQ:TGTX - Nasdaq - US88322Q1085 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 329.00M | 233.66M | 2.79M | 6.69M | 152.00K | |||
| Cost Of Goods | 38.49M | 14.13M | 265.00K | 790.00K | N/A | |||
| Gross Profit | 290.52M | 219.53M | 2.52M | 5.90M | N/A | |||
| Operating Expenses | 248.59M | 198.90M | 220.84M | 350.67M | 273.75M | |||
| Research and Development | 94.29M | 76.19M | 125.35M | 222.58M | 165.90M | |||
| Selling, General, and Administrative Expenses | 154.30M | 122.71M | 95.48M | 128.09M | 107.85M | |||
| Operating Income | 41.93M | 20.63M | -218.32M | -344.77M | -273.59M | |||
| Interest Income/Expense | -24.03M | -12.62M | -10.19M | -5.64M | -6.33M | |||
| Other Income/Expense | 7.69M | 5.04M | 4.70M | 2.31M | 542.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 25.59M | 13.06M | -223.81M | -348.10M | -279.38M | |||
| Income Tax | 2.21M | 390.00K | 0.00 | N/A | N/A | |||
| Net Income | 23.38M | 12.67M | -223.81M | -348.10M | -279.38M | |||
| EBITDA | 42.00M | 20.84M | -218.01M | -344.49M | -273.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.15 | 0.09 | -1.65 | -2.63 | -2.42 | |||
| Non GAAP EPS | 0.14 | 0.01 | -1.46 | -2.63 | -2.27 | |||
| Statistics | ||||||||
| Gross Profit Margin | 88.30% | 93.95% | 90.48% | 88.19% | N/A | |||
| Profit Margin | 7.11% | 5.42% | -8036.34% | -5204.08% | -183803.29% | |||
| Operating Profit Margin | 12.74% | 8.83% | -7838.99% | -5154.28% | -179996.05% | |||
All data in USD